ZA961018B - Oral dosage-forms containing a beta-lactam antibiotic. - Google Patents

Oral dosage-forms containing a beta-lactam antibiotic.

Info

Publication number
ZA961018B
ZA961018B ZA9601018A ZA961018A ZA961018B ZA 961018 B ZA961018 B ZA 961018B ZA 9601018 A ZA9601018 A ZA 9601018A ZA 961018 A ZA961018 A ZA 961018A ZA 961018 B ZA961018 B ZA 961018B
Authority
ZA
South Africa
Prior art keywords
pct
beta
lactam antibiotic
granulate
oral dosage
Prior art date
Application number
ZA9601018A
Other languages
English (en)
Inventor
Gerrit Jan Sijbrands
Robertus Cornelis Van Koutrik
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Publication of ZA961018B publication Critical patent/ZA961018B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ZA9601018A 1995-02-08 1996-02-08 Oral dosage-forms containing a beta-lactam antibiotic. ZA961018B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200313 1995-02-08

Publications (1)

Publication Number Publication Date
ZA961018B true ZA961018B (en) 1997-08-08

Family

ID=8220003

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9601018A ZA961018B (en) 1995-02-08 1996-02-08 Oral dosage-forms containing a beta-lactam antibiotic.

Country Status (19)

Country Link
US (1) US5948422A (cs)
EP (1) EP0801559B1 (cs)
CN (1) CN1125636C (cs)
AT (1) ATE216576T1 (cs)
AU (1) AU4789696A (cs)
BG (1) BG63528B1 (cs)
BR (1) BR9607189A (cs)
CZ (1) CZ293718B6 (cs)
DE (1) DE69620866T2 (cs)
DK (1) DK0801559T3 (cs)
EA (2) EA000361B1 (cs)
ES (1) ES2175073T3 (cs)
HU (1) HU227938B1 (cs)
MX (1) MX9706062A (cs)
NO (1) NO319993B1 (cs)
PL (1) PL186386B1 (cs)
PT (1) PT801559E (cs)
WO (1) WO1996024337A1 (cs)
ZA (1) ZA961018B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AU4011397A (en) * 1996-07-16 1998-02-09 Gist-Brocades B.V. Beta-lactam granules free of organic solvents
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
ATE219658T1 (de) * 1998-03-06 2002-07-15 Eurand Int Schnell zerfallende tablette
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
US20040034039A1 (en) * 2000-09-22 2004-02-19 Yoshinori Nakano Solid preparations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
BR0206979A (pt) * 2001-02-05 2004-04-20 Scherer Technologies Inc R P Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
RU2190403C1 (ru) * 2001-09-27 2002-10-10 Нестерук Владимир Викторович Фармацевтическая композиция, обладающая антибактериальным действием, и способ ее получения
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
KR101019769B1 (ko) * 2002-10-02 2011-03-04 메이지 세이카 가부시키가이샤 경구 흡수성이 개선된 항균성 약제학적 조성물
NO346973B1 (en) * 2002-12-20 2023-03-20 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
WO2005018540A2 (en) * 2003-07-03 2005-03-03 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
JP2009515993A (ja) * 2005-11-17 2009-04-16 ノバルティス アクチエンゲゼルシャフト 医薬組成物
EP1998748B1 (en) 2006-03-16 2015-01-14 NicoNovum AB Improved snuff composition
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
AU2007278850B2 (en) * 2006-07-28 2013-06-06 Sertocell Biotechnology (Us) Corp. Adult sertoli cells and uses thereof
WO2010031552A1 (en) * 2008-09-17 2010-03-25 Niconovum Ab Process for preparing snuff composition
EP2367422A4 (en) * 2008-12-17 2013-01-09 Altheus Therapeutics Inc FORMULAS FOR LAVATION
WO2023204773A1 (en) * 2022-04-20 2023-10-26 Bilim Ilac Sanayii Ve Ticaret A.S. Tablet formulations for the treatment of urinary system infections and method for the preparation of such formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3344030A (en) * 1964-06-15 1967-09-26 American Home Prod Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables
DE2251250C3 (de) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten
DE2251249A1 (de) * 1972-10-19 1974-05-02 Hoechst Ag Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
ATE108996T1 (de) * 1988-02-25 1994-08-15 Brocades Pharma Bv Verfahren zur herstellung eines pharmazeutischen granulats.
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
EP0755258B1 (en) * 1994-04-13 2002-01-23 Research Corporation Technologies, Inc Methods of treating disease using sertoli cells and allografts or xenografts
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin

Also Published As

Publication number Publication date
NO973646D0 (no) 1997-08-07
BR9607189A (pt) 1997-11-11
DE69620866D1 (de) 2002-05-29
EA199900205A1 (ru) 2000-06-26
CN1125636C (zh) 2003-10-29
NO973646L (no) 1997-09-11
ES2175073T3 (es) 2002-11-16
DE69620866T2 (de) 2003-02-27
PL321567A1 (en) 1997-12-08
NO319993B1 (no) 2005-10-10
CZ293718B6 (cs) 2004-07-14
US5948422A (en) 1999-09-07
CZ230297A3 (en) 1997-11-12
EA199700093A1 (ru) 1998-02-26
PT801559E (pt) 2002-09-30
EP0801559B1 (en) 2002-04-24
ATE216576T1 (de) 2002-05-15
EA003736B1 (ru) 2003-08-28
WO1996024337A1 (en) 1996-08-15
MX9706062A (es) 1997-10-31
HUP9801677A2 (hu) 1998-11-30
EA000361B1 (ru) 1999-06-24
DK0801559T3 (da) 2002-06-17
HUP9801677A3 (en) 1999-05-28
BG101822A (en) 1998-04-30
AU4789696A (en) 1996-08-27
BG63528B1 (bg) 2002-04-30
EP0801559A1 (en) 1997-10-22
PL186386B1 (pl) 2004-01-30
HU227938B1 (en) 2012-06-28
CN1173816A (zh) 1998-02-18

Similar Documents

Publication Publication Date Title
ZA961018B (en) Oral dosage-forms containing a beta-lactam antibiotic.
ZA957670B (en) Pharmaceutical preparation containing metformin and processes for the production thereof
TW263499B (cs)
JO1969B1 (en) Granulation process for the preparation of rapidly dissolving and dissolving compounds containing a high amount of the drug
ZA965237B (en) A composition and a process for the preparation thereof
HUT72970A (en) Risperidone pamoate, pharmaceutical composition containing it and process for their production
IL141881A0 (en) Hydrocolloid confectionery
IL115920A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION
GB9517883D0 (en) Improved pharmaceutical ion exchange resin composition
MXPA00012199A (es) Composicion de goma de gelano modificada, proceso para la preparacion de la misma y uso de esta.
HU9700903D0 (en) Sulfonamide-substituted chromanes, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them
HUP9601358A3 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
HU9601321D0 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them
BR9909637A (pt) Processo para a produção de um tablete de uma composição particulada compactada, tablete de composição particulada compactada, e, usos de cristais ou acetato de sódio hidratado ou anidro, acetato de potássio ou misturas dos mesmos e de cristais ou triidrato de acetato de sódio hidratado ou anidro, acetato de potássio ou mistura dos mesmos
HUP9802492A3 (en) Benzisoxazole and indazole derivatives as antipsychotic agents, process for their preparation and pharmaceutical compositions containing the same
HUP9901260A3 (en) Optically active phenylpyrimidine derivative as analgesic agent, process for producing it, pharmaceutical composition containing it and its intermediate
HU905725D0 (en) Process for producing 1,4-disubstituted 5-aryl-carbamoyl-4(6)-oxo-6(4)-oxido-pyrimidine-betaine derivatives and anthelmintic preparatives containing these compounds as active substance
HUP0103347A3 (en) Aminoalcohol derivatives and their use as betha 3 adrenergic agonists, process for their preparation and pharmaceutical compositions containing them
GR3036220T3 (en) Process for reducing sulfur and vat dyes
PL331588A1 (en) Granulated products containing a water-soluble compound and cellulose
HUP9900263A3 (en) 11-acetyl-12,13-dioxabicyclo[8.2.1.]tridecenon derivatives, process for producing them and pharmaceutical compositions containing them
TW334424B (en) L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them
HU9401032D0 (en) New benzimidazol-2-yl derivatives, process for producing them and pharmaceutical compositions containing them